| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Sep'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total revenues | |||||||||||||
37,217 | 34,631 | 26,574 | 16,079 | 10,676 | 7,065 | 0 | 0 | 0 | - | 0 | 0 | - | - |
Gross margin | |||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - |
Licensing revenues | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Costs and expenses: | |||||||||||||
Cost of product sales | |||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - | - |
Net product revenues | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | - |
Cost of product sales | |||||||||||||
- | - | 3,934 | 2,864 | - | 1,588 | 870 | 551 | 200 | 0 | 0 | 0 | 0 | - |
Research and development | |||||||||||||
21,153 | 20,783 | 18,767 | 16,209 | 12,960 | 10,099 | 7,948 | 11,600 | 14,303 | 16,832 | 0 | 0 | 0 | 0 |
Selling, general and administrative | |||||||||||||
104,875 | 104,155 | 101,271 | 98,087 | 93,947 | 95,618 | 90,441 | 74,908 | 56,636 | 31,698 | 0 | 0 | 0 | 0 |
Total operating expenses | |||||||||||||
0 | - | 122,384 | 115,572 | 0 | - | 99,259 | 87,059 | 71,139 | 48,530 | 0 | 0 | 0 | 0 |
Loss from operations | |||||||||||||
-94,723 | -95,601 | -97,398 | -101,081 | -98,357 | -100,240 | -95,218 | -84,920 | -70,274 | -48,530 | 0 | 0 | 0 | 0 |
Other (income) expense: | |||||||||||||
Grant and other income | |||||||||||||
- | - | 30 | 72 | - | 406 | 0 | 0 | 0 | - | - | - | - | - |
Grant and other income | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 |
Interest income | |||||||||||||
2,007 | 2,359 | 2,674 | 2,795 | 2,661 | 2,453 | 1,885 | 1,266 | 744 | 303 | 0 | 0 | 0 | 0 |
Interest expense | |||||||||||||
10,098 | 9,623 | 9,523 | 9,512 | 9,424 | 9,229 | 6,903 | 4,542 | 2,241 | 910 | 0 | 0 | 0 | 0 |
Foreign currency losses | |||||||||||||
-66 | -33 | -69 | -30 | -57 | -48 | -6 | 21 | 70 | 73 | 0 | 0 | 0 | 0 |
Loss on extinguishment of debt | |||||||||||||
- | - | 0 | - | - | - | 0 | - | - | - | - | - | - | - |
Net loss | |||||||||||||
-110,035 | -110,053 | -111,441 | -107,756 | -104,960 | -106,658 | -99,827 | -87,772 | -71,399 | -48,902 | 0 | 0 | 0 | 0 |
Net loss per share of common stock, basic and diluted (in USD per share) | |||||||||||||
-0.63 | -0.58 | -0.69 | -0.66 | -0.70 | -0.62 | -0.61 | -0.64 | -0.81 | - | - | - | - | - |
Weighted average common shares outstanding, basic and diluted (in shares) | |||||||||||||
45,906 | 43,489 | 41,454 | 41,310 | 41,256 | 41,319 | 41,207 | 38,688 | 37,849 | - | - | - | - | - |
Deemed dividend | |||||||||||||
- | - | - | - | - | - | - | - | - | 11,969 | 0 | 0 | 0 | 0 |
Accretion to redemption value | |||||||||||||
- | - | - | - | - | - | - | - | - | 1,096 | 0 | 0 | 0 | 0 |
Net loss attributable to common stockholders | |||||||||||||
- | - | - | - | - | - | - | - | - | -61,967 | 0 | 0 | 0 | 0 |
basic (in USD per share) | |||||||||||||
- | - | - | - | - | - | - | - | - | 4.63 | -4.23 | -3.16 | -2.87 | -2.32 |
diluted (in USD per share) | |||||||||||||
- | - | - | - | - | - | - | - | - | 4.63 | -4.23 | -3.16 | -2.87 | -2.32 |
basic (in shares) | |||||||||||||
- | - | - | - | - | - | - | - | - | 31,793 | 4,067 | 4,067 | 4,067 | - |
diluted (in shares) | |||||||||||||
- | - | - | - | - | - | - | - | - | 31,793 | 4,067 | 4,067 | 4,067 | 4,050 |
Net product revenues | |||||||||||||
Total revenues | |||||||||||||
33,487 | 30,401 | 22,344 | 15,579 | 10,176 | 7,065 | 0 | 0 | 0 | - | - | - | - | - |
Licensing revenues | |||||||||||||
Total revenues | |||||||||||||
3,730 | 4,230 | 4,230 | 500 | 500 | 0 | 0 | 0 | 0 | - | - | - | - | - |